On May 24, 2023 Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for cancer, reported that it will participate in three upcoming investor conferences (Press release, Allogene, MAY 24, 2023, View Source [SID1234631989]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

TD Cowen 4th Annual Oncology Innovation Summit
Tuesday, May 30, 2023
6:30AM PT/9:30AM ET

Jefferies Healthcare Conference
Friday, June 9, 2023
9:45AM PT/12:45PM ET

Goldman Sachs 44th Annual Global Healthcare Conference
Wednesday, June 14, 2023
1:20PM PT/4:20PM ET

Any available webcasts will be posted to the Company’s website at www.allogene.com under the Investors tab in the News and Events section. Following a live webcast, a replay will be available on the Company’s website for approximately 30 days.